title: Impact of mutations conferring reduced susceptibility to lamivudine on the response to antiretroviral therapy.
authors.forename: C F
authors.initials: CF
authors.lastname: Perno
authors.forename: A
authors.initials: A
authors.lastname: Cozzi-Lepri
authors.forename: C
authors.initials: C
authors.lastname: Balotta
authors.forename: F
authors.initials: F
authors.lastname: Forbici
authors.forename: M
authors.initials: M
authors.lastname: Violin
authors.forename: A
authors.initials: A
authors.lastname: Bertoli
authors.forename: G
authors.initials: G
authors.lastname: Facchi
authors.forename: P
authors.initials: P
authors.lastname: Pezzotti
authors.forename: G
authors.initials: G
authors.lastname: Angarano
authors.forename: C
authors.initials: C
authors.lastname: Arici
authors.forename: P
authors.initials: P
authors.lastname: Narciso
authors.forename: A
authors.initials: A
authors.lastname: Orani
authors.forename: E
authors.initials: E
authors.lastname: Raise
authors.forename: A
authors.initials: A
authors.lastname: Scalzini
authors.forename: A
authors.initials: A
authors.lastname: Poggio
authors.forename: G
authors.initials: G
authors.lastname: Ippolito
authors.forename: M
authors.initials: M
authors.lastname: Moroni
authors.forename: A D
authors.initials: AD
authors.lastname: Monforte
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D000328:Adult; D000368:Aged; D023241:Antiretroviral Therapy, Highly Active; D024882:Drug Resistance, Viral; D005260:Female; D054303:HIV Reverse Transcriptase / Q000235:genetics*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009154:Mutation; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*
chemical_list: D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine; D054303:HIV Reverse Transcriptase